XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.2
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
SCHEDULE OF DISAGGREGATED REVENUE

For the three and six months ended June 30, 2022 and 2021, the Company had the following disaggregated revenue:

  

   Three Months Ended June 30,   Six Months Ended June 30, 
   2022   %   2021   %   2022   %   2021   % 
Telehealth revenue  $22,267,963    73%  $15,799,610    71%  $44,866,024    75%  $29,082,925    72%
WorkSimpli revenue   8,190,535    27%   6,514,001    29%   14,635,311    25%   11,428,798    28%
Total net revenue  $30,458,498    100%  $22,313,611    100%  $59,501,335    100%  $40,511,723    100%
SCHEDULE OF CONTRACT WITH CUSTOMER LIABILITY

The Company records deferred revenues when cash payments are received or due in advance of its performance. The Company’s deferred revenues relate to payments received for the in-process monthly or yearly contracts with customers and a portion attributable to the yet to be recognized initial 14-day trial period collections.

 

   Three Months Ended June 30,   Six Months Ended June 30, 
   2022   2021   2022   2021 
Beginning of period  $1,788,555   $1,339,309   $1,499,880   $916,880 
Additions   7,853,216    6,183,965    14,221,187    11,210,719 
Revenue recognized   (7,649,269)   (6,141,336)   (13,728,565)   (10,745,661)
End of period  $1,992,502   $1,381,938   $1,992,502   $1,381,938 
SUMMARY OF INVENTORY

As of June 30, 2022 and December 31, 2021, the Company’s inventory consisted of the following:

 

   June 30,   December 31, 
   2022   2021 
         
Finished Goods - Products  $2,084,799   $1,592,654 
Raw materials and packaging components   937,459    81,427 
Inventory reserve   (57,016)   (57,481)
Total Inventory - net  $2,965,242   $1,616,600 
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

The following table summarizes the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive, even though the exercise price could be less than the average market price of the common shares:

 

  

Three Months

Ended

  

Three Months

Ended

  

Six Months

Ended

  

Six Months

Ended

 
   June 30, 2022   June 30, 2021   June 30, 2022   June 30, 2021 
                 
Series B Preferred Stock   1,334,293    1,194,293    1,316,841    1,178,379 
Restricted Stock Units (RSUs)   1,445,750    664,375    1,429,125    355,938 
Stock options   4,259,198    4,013,400    4,318,065    4,204,200 
Warrants   3,859,638    3,984,787    3,859,638    3,767,629 
Potentially dilutive securities   10,898,879    9,856,855    10,923,669    9,506,146